Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

astrazeneca ab - propranolol hydrochloride - film-coated tablet - 10 milligram(s) - beta blocking agents, non-selective; propranolol

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

astrazeneca ab - budesonide micronised; formoterol fumarate dihydrate (micronised) - pressurised inhalation, suspension - 200 mcg/6 microgram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and budesonide

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

astrazeneca ab - atenolol; chlorthalidone - film-coated tablet - 50 mg/12.5 milligram(s) - beta blocking agents, selective, and other diuretics; atenolol and other diuretics

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

astrazeneca ab - atenolol; chlorthalidone - film-coated tablet - 100 mg/25 milligram(s) - beta blocking agents, selective, and other diuretics; atenolol and other diuretics

Μάλτα - Αγγλικά - Medicines Authority

astrazeneca ab se-151 85, södertälje, sweden - chlortalidone, atenolol - film-coated tablet - chlortalidone 25 mg atenolol 100 mg - beta blocking agents

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

astrazeneca ab - terbutaline sulfate - solution for injection/infusion - 500 microgram(s)/millilitre - selective beta-2-adrenoreceptor agonists; terbutaline

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

astrazeneca pharmaceuticals lp - azd-1222 (unii: b5s3k2v0g8) (azd-1222 - unii:b5s3k2v0g8) -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - chadox1-s, quantity: 100000000000 vp/ml - injection, solution - excipient ingredients: histidine; magnesium chloride hexahydrate; sucrose; disodium edetate; polysorbate 80; sodium chloride; histidine hydrochloride monohydrate; ethanol absolute; water for injections - vaxzevria has provisional approval for the indication:,active immunisation of individuals greater than or equal to 18 years old for the prevention of coronavirus disease 2019 (covid-19) caused by sars-cov-2.,the use of this vaccine should be in accordance with official recommendations.,the decision has been made on the basis of short term efficacy and safety data. continued approval is dependent upon the evidence of longer-term efficacy and safety from ongoing clinical trials and post-market assessment.

Σιγκαπούρη - Αγγλικά - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - esomeprazole - injection, powder, for solution - 40 mg - esomeprazole 40 mg

Σιγκαπούρη - Αγγλικά - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - metformin hydrochloride + 0.5% magnesium stearate; saxagliptin hydrochloride anhydrous 2.79mg eqv saxagliptin - tablet, film coated, extended release - 1000.0 mg - metformin hydrochloride + 0.5% magnesium stearate 1000.0 mg; saxagliptin hydrochloride anhydrous 2.79mg eqv saxagliptin 2.5mg